Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“A Chain Only as Strong as Its Weakest Link”: An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19
Radu Crișan-Dabija, Cristina Alice Pavel, Iolanda Valentina Popa, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4327-4338
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches
Innokenty A. Savin, Marina A. Zenkova, Aleksandra V. Sen’kova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14959-14959
Open Access | Times Cited: 120
Virus infection induced pulmonary fibrosis
Wei Huang, Xiao Xiao Tang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 110
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
Shiva Ambardar, Stephanie Hightower, Nikhil Huprikar, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2452-2452
Open Access | Times Cited: 107
Iron oxide nanoparticles augment the intercellular mitochondrial transfer–mediated therapy
Ting Huang, Tianyuan Zhang, Xinchi Jiang, et al.
Science Advances (2021) Vol. 7, Iss. 40
Open Access | Times Cited: 83
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70
Persistence of COVID-19 Symptoms after Recovery in Mexican Population
Carlos E. Galván-Tejada, Cintya Fabiola Herrera-García, Susana Godina-González, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 24, pp. 9367-9367
Open Access | Times Cited: 68
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 33
Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking
Jun‐Feng Cao, Lianglei Li, Li Xiong, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100252-100252
Open Access | Times Cited: 32
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 77-83
Open Access | Times Cited: 22
Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
Gustavo Ramírez-Martínez, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 8, pp. 352-368
Open Access | Times Cited: 24
Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019
Ding‐Hui Peng, Yi Luo, Lijun Huang, et al.
Clinica Chimica Acta (2021) Vol. 517, pp. 48-53
Open Access | Times Cited: 29
Severe COVID-19 pneumonia leads to post-COVID-19 lung abnormalities on follow-up CT scans
Takuya Hino, Mizuki Nishino, Vladimir I. Valtchinov, et al.
European Journal of Radiology Open (2023) Vol. 10, pp. 100483-100483
Open Access | Times Cited: 10
COVID-19: A threat to the respiratory system
Ghulam Rasool, Waqas Khan, Arif Khan, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 3
A metabolomic approach to elucidate the inhibitory effects of baicalin in pulmonary fibrosis
Hong Chang, Hongyu Meng, Wanfu Bai, et al.
Pharmaceutical Biology (2021) Vol. 59, Iss. 1, pp. 1014-1023
Open Access | Times Cited: 21
Optimal intervention strategies to mitigate the COVID-19 pandemic effects
Andreas Kasis, Stelios Timotheou, Nima Monshizadeh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways
Xiuhua Wang, Wei Wan, Jing Lü, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2022) Vol. 172, pp. 177-192
Closed Access | Times Cited: 15
Effects of Resveratrol on Pulmonary Fibrosis via TGF-β/Smad/ERK Signaling Pathway
Lei Liu, Bin Liu, Liang Li, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 03, pp. 651-676
Closed Access | Times Cited: 8
The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study
Neslihan Çelik, Onur Çelik, Esra Laloğlu, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2023) Vol. 56
Open Access | Times Cited: 8
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice
Radu Crișan-Dabija, Ileana Antohe, Antigona Trofor, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 19, Iss. 12, pp. 1553-1562
Open Access | Times Cited: 18
Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis
Sourabh Soni, Laura Antonescu, Kaylin Ro, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 10, pp. 1807-1822
Closed Access | Times Cited: 2
Materdicine and Medmaterial
Hui Huang, Yu Chen
Journal of Inorganic Materials (2022) Vol. 37, Iss. 11, pp. 1151-1151
Open Access | Times Cited: 6
New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions
Д. И. Трухан
Meditsinskiy sovet = Medical Council (2022) Vol. 16, Iss. 18, pp. 154-161
Open Access | Times Cited: 6
COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease
Stylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, et al.
Journal of Scleroderma and Related Disorders (2022) Vol. 8, Iss. 2, pp. 113-119
Open Access | Times Cited: 5
Severe progression of idiopathic pulmonary fibrosis post-COVID-19 infection
N Earl, Dillon Schoeneberg, Philip D Davidson
BMJ Case Reports (2021) Vol. 14, Iss. 10, pp. e244472-e244472
Open Access | Times Cited: 7
Chest high-resolution computed tomography in patients with connective tissue disease: pulmonary conditions beyond “the usual suspects”
Lorenzo Cereser, Emanuele Passarotti, Alessandro De Pellegrin, et al.
Current Problems in Diagnostic Radiology (2021) Vol. 51, Iss. 5, pp. 759-767
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top